Advanced Medical Solutions Group (LON:AMS) Earns Buy Rating from Berenberg Bank

Advanced Medical Solutions Group (LON:AMS)‘s stock had its “buy” rating reaffirmed by analysts at Berenberg Bank in a research report issued to clients and investors on Tuesday,Digital Look reports. They presently have a GBX 300 ($3.67) price target on the stock. Berenberg Bank’s price objective indicates a potential upside of 37.61% from the company’s previous close.

Advanced Medical Solutions Group Stock Up 14.4 %

Shares of AMS stock traded up GBX 27.40 ($0.34) during trading hours on Tuesday, hitting GBX 218 ($2.67). 1,169,792 shares of the company were exchanged, compared to its average volume of 483,901. The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39. Advanced Medical Solutions Group has a one year low of GBX 176.60 ($2.16) and a one year high of GBX 275.83 ($3.38). The business’s 50-day simple moving average is GBX 204.23 and its two-hundred day simple moving average is GBX 220.08. The stock has a market capitalization of £467.72 million, a price-to-earnings ratio of 4,360.00, a P/E/G ratio of 5.00 and a beta of 0.74.

Insiders Place Their Bets

In related news, insider Eddie Johnson sold 34,235 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of GBX 218 ($2.67), for a total transaction of £74,632.30 ($91,326.85). 3.12% of the stock is currently owned by corporate insiders.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.